Turn Therapeutics Inc. (TTRX) — Dilution Risk Analysis

Current Snapshot

Turn Therapeutics Inc. (TTRX) has a DilutionWatch score of 48/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
29,788,040 Source
Public Float
11,128,514 Source
Float as % of Outstanding
37.4%

Dilution Risk Score

Score: 48/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 4 5, EFFECT 2, 8-K 1, 3 1.

FormFiledAccession
xbrl 2026-06-30 xbrl-5508-xbrl_warrant
4 2026-04-03 0001213900-26-039712
4 2026-04-03 0001213900-26-039713
4 2026-04-03 0001213900-26-039714
4 2026-04-03 0001213900-26-039715
EFFECT 2026-04-02 9999999995-26-001062
EFFECT 2026-04-02 9999999995-26-001065
8-K 2026-03-24 0001213900-26-033233
3 2026-02-04 0001213900-26-011816
4 2026-02-04 0001213900-26-011817

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 46 months Source
Three-year share count growth 6.3% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 48/10) Source
Cash Runway
46 months Source
Share Count Growth (3-Year)
6.3% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.